Inflammation markers in newly diagnosed b-cell blood cancers
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at blood tests to find markers of inflammation in people newly diagnosed with B-cell blood cancers (such as certain lymphomas, leukemias, and multiple myeloma). It may help doctors better understand these diseases and how they affect the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a newly diagnosed B-cell blood cancer (like certain lymphomas, leukemias, or multiple myeloma).
- You must not have been treated for a B-cell blood cancer before (this must be your first diagnosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain markers in your tumor sample might predict how your lymphoma will behave. It aims to see if these markers can help guide treatment decisions, so your care can be more personalized.
This study looks at routine blood test results (called CBC) in people who have just been diagnosed with acute lymphoblastic leukemia (ALL), a type of blood cancer. The goal is to see if certain blood levels can help doctors understand the disease better and guide treatment.
This study looks at certain proteins on B-cell blood cancer cells to understand them better. It may help doctors learn more about these cancers, but it is not a treatment trial.
This study looks at certain markers on your blood cancer cells to understand them better. By joining, you help doctors learn more about your disease, which may guide future care.
This study looks at how certain blood tests (like CRP, albumin, and their ratios) might help predict how well treatment works for newly diagnosed DLBCL. If you are getting R-CHOP, this trial could help doctors better understand your response to therapy.
This study checks if two natural substances in your blood (called cytokines) are linked to how active your leukemia is. It aims to help doctors better understand and possibly predict the disease, which could guide future treatment.
Hear when a new B-cell Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.